We are live on
!
Find out more
WP
Waycross Partners Portfolio holdings
AUM
$1.05B
1-Year Est. Return
20.92%
This Fund
S&P 500
This Quarter
Est. Return
+3.48%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
+$59.6M
(+5.1%)
Cap. Flow
+$26.8M
Cap. Flow
% of AUM
2.2%
Top 10 Holdings %
Top 10 Hldgs %
50.4%
Holding
99
New
4
Increased
23
Reduced
10
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$30.7M |
| 2 |
Intuit
INTU
|
+$30M |
| 3 |
Procter & Gamble
PG
|
+$14.4M |
| 4 |
Mastercard
MA
|
+$5.74M |
| 5 |
MRSH
Marsh
MRSH
|
+$5.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$27.8M |
| 2 |
Southern Company
SO
|
+$14.4M |
| 3 |
Target
TGT
|
+$13.9M |
| 4 |
Broadcom
AVGO
|
+$8.45M |
| 5 |
Goldman Sachs
GS
|
+$5.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.04% |
| 2 | Financials | 15.36% |
| 3 | Industrials | 12.27% |
| 4 | Communication Services | 11.54% |
| 5 | Consumer Discretionary | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Phillips 66
PSX
$82.5B
| $383K | 0.03% |
2,965
| – | – |
|
77
US Bancorp
USB
$100B
| $375K | 0.03% |
7,021
| – | – |
|
78
CME Group
CME
$93.5B
| $367K | 0.03% |
1,344
| – | – |
|
79
Duke Energy
DUK
$101B
| $359K | 0.03% |
3,061
| – | – |
|
80
Consolidated Edison
ED
$41.3B
| $358K | 0.03% |
3,604
| – | – |
|
81
Johnson & Johnson
JNJ
$643B
| $352K | 0.03% |
1,700
| – | – |
|
82
FirstEnergy
FE
$28.7B
| $333K | 0.03% |
7,449
| – | – |
|
83
Oracle
ORCL
$346B
| $331K | 0.03% |
1,700
| – | – |
|
84
Abbott
ABT
$187B
| $312K | 0.03% |
2,489
| – | – |
|
85
Prudential Financial
PRU
$43B
| $311K | 0.03% |
2,755
| – | – |
|
|
86
Target
TGT
$65.5B
| $309K | 0.03% |
3,163
-150,749
| -98% | -$13.9M |
|
87
Chevron
CVX
$374B
| $300K | 0.02% |
1,967
| – | – |
|
88
Kimberly-Clark
KMB
$37.5B
| $279K | 0.02% |
2,769
| – | – |
|
89
Verizon
VZ
$201B
| $265K | 0.02% |
6,494
| – | – |
|
90
Merck
MRK
$326B
| $263K | 0.02% |
2,500
| – | – |
|
91
Philip Morris
PM
$312B
| $260K | 0.02% |
1,619
| – | – |
|
92
Bristol-Myers Squibb
BMY
$130B
| $246K | 0.02% |
4,557
| – | – |
|
93
Kraft Heinz
KHC
$32.4B
| $219K | 0.02% |
9,028
| – | – |
|
94
Conagra Brands
CAG
$7.38B
| $175K | 0.01% |
10,125
| – | – |
|
|
EXAS
95
DELISTED
Exact Sciences
EXAS
| – | – |
-25,000
| Closed | -$1.37M |
|
|
96
Idexx Laboratories
IDXX
$44.9B
| – | – |
-43,471
| Closed | -$27.8M |
|
97
Kenvue
KVUE
$37.9B
| – | – |
-200,000
| Closed | -$3.25M |
|
98
UnitedHealth
UNH
$389B
| – | – |
-5,000
| Closed | -$1.73M |
|
99
Wells Fargo
WFC
$263B
| – | – |
-45,000
| Closed | -$3.77M |
|
Similar funds
LPC
HWCM
AA
CIA
CIA
SPC
LAM
CA
Waycross Partners's Q4 2025 Portfolio in Review
As of Q4 2025, Waycross Partners held 99 positions worth $1.22B, up 5.1% from $1.16B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Waycross Partners's Q4 2025 filing shows 4 new, 23 increased, 10 reduced and 5 closed positions. Its largest new stake was Sherwin-Williams: 91,796 shares worth $29.7M. The largest sale was Idexx Laboratories, an estimated $27.8M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Industrials.
- Waycross Partners's largest Q4 2025 buy was Sherwin-Williams: 91,796 shares worth $29.7M.
- Waycross Partners added most to Procter & Gamble in Q4 2025, an estimated $14.4M increase.
- Waycross Partners's biggest Q4 2025 reduction was Southern Company, cutting an estimated $14.4M.
- Waycross Partners fully exited Idexx Laboratories in Q4 2025, selling an estimated $27.8M.
- Waycross Partners's ten largest holdings make up 50% of its $1.22B portfolio in Q4 2025.
- Waycross Partners opened 4 new positions and closed 5 in Q4 2025.
- Waycross Partners's portfolio value rose 5.1% quarter-over-quarter to $1.22B.
Based on Waycross Partners's 13F filing for Q4 2025, filed 14 Jan 2026.